These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27825810)
1. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients. Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810 [TBL] [Abstract][Full Text] [Related]
2. XAF1 is frequently methylated in human esophageal cancer. Chen XY; He QY; Guo MZ World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma. Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234 [TBL] [Abstract][Full Text] [Related]
5. Analysis of SDHD promoter mutations in various types of melanoma. Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518 [TBL] [Abstract][Full Text] [Related]
6. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. van der Velden PA; Zuidervaart W; Hurks MHMH; Pavey S; Ksander BR; Krijgsman E; Frants RR; Tensen CP; Willemze R; Jager MJ; Gruis NA Int J Cancer; 2003 Sep; 106(4):472-479. PubMed ID: 12845640 [TBL] [Abstract][Full Text] [Related]
7. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398 [TBL] [Abstract][Full Text] [Related]
8. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells. Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma. Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382 [TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage. Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105 [TBL] [Abstract][Full Text] [Related]
11. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma. Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571 [TBL] [Abstract][Full Text] [Related]
12. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576 [TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma. de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374 [TBL] [Abstract][Full Text] [Related]
15. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma. Mithani SK; Smith IM; Califano JA Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880 [TBL] [Abstract][Full Text] [Related]
16. Functional modulation of IGF-binding protein-3 expression in melanoma. Dar AA; Majid S; Nosrati M; de Semir D; Federman S; Kashani-Sabet M J Invest Dermatol; 2010 Aug; 130(8):2071-9. PubMed ID: 20357812 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769 [TBL] [Abstract][Full Text] [Related]
18. Seladin-1 expression is regulated by promoter methylation in adrenal cancer. Simi L; Malentacchi F; Luciani P; Gelmini S; Deledda C; Arvia R; Mannelli M; Peri A; Orlando C BMC Cancer; 2010 May; 10():201. PubMed ID: 20465827 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients. Villalba M; Diaz-Lagares A; Redrado M; de Aberasturi AL; Segura V; Bodegas ME; Pajares MJ; Pio R; Freire J; Gomez-Roman J; Montuenga LM; Esteller M; Sandoval J; Calvo A Oncotarget; 2016 Apr; 7(16):22752-69. PubMed ID: 26989022 [TBL] [Abstract][Full Text] [Related]
20. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]